The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma: A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines

The purpose of this study was to investigate the efficacy and safety of programmed cell death 1 (PD-1) and programmed cell death 1 ligand (PD-L1) inhibitors using a meta-analysis of present trials for advanced melanoma. A fully recursive literature search of the primary electronic databases for avai...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Xiuwen, Wang, Haijuan, Ma, Fei, Qian, Haili, Yi, Zongbi, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839950/
https://www.ncbi.nlm.nih.gov/pubmed/26986169
http://dx.doi.org/10.1097/MD.0000000000003134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839950/
https://www.ncbi.nlm.nih.gov/pubmed/26986169
http://dx.doi.org/10.1097/MD.0000000000003134

Ejemplares similares